• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病的肠外表现和并发症。

Extraintestinal manifestations and complications in IBD.

机构信息

Department of Internal Medicine I, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93042 Regensburg, Germany.

出版信息

Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9.

DOI:10.1038/nrgastro.2013.117
PMID:23835489
Abstract

More than one-third of patients with IBD are affected by extraintestinal manifestations or extraintestinal complications beyond the intestinal manifestation of the disease. The most common manifestations include arthropathies, mucocutaneous and ophthalmological manifestations, as well as conditions affecting the hepatobiliary system, both in Crohn's disease and ulcerative colitis. However, less frequent manifestations, such as pulmonary or neurological manifestations, should also be considered in patients with IBD. Several extraintestinal manifestations follow the course of the underlying intestinal activity, whereas others are independent from the intestinal inflammation. Extraintestinal complications such as iron-deficiency anaemia and osteoporosis are consequences of the intestinal disease or of disease-specific treatment. As extraintestinal manifestations and complications strongly influence quality of life, and to avoid severe complications, adequate treatment is mandatory in affected patients. We provide a comprehensive overview of different extraintestinal manifestations and complications, including their management, in patients with IBD.

摘要

超过三分之一的 IBD 患者受到肠道外表现或肠道外并发症的影响,这些表现超出了疾病的肠道表现。最常见的表现包括关节病、黏膜皮肤和眼部表现,以及影响肝胆系统的疾病,无论是在克罗恩病还是溃疡性结肠炎中。然而,在 IBD 患者中,也应考虑到不太常见的表现,如肺部或神经系统表现。一些肠道外表现遵循潜在肠道活动的过程,而另一些则与肠道炎症无关。缺铁性贫血和骨质疏松症等肠道外并发症是肠道疾病或疾病特异性治疗的后果。由于肠道外表现和并发症强烈影响生活质量,为了避免严重的并发症,患有这些疾病的患者必须进行充分的治疗。我们提供了 IBD 患者不同肠道外表现和并发症的全面概述,包括其管理。

相似文献

1
Extraintestinal manifestations and complications in IBD.炎症性肠病的肠外表现和并发症。
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9.
2
[Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].[匈牙利维斯普雷姆县炎症性肠病的肠外表现:一项25年随访研究的结果]
Orv Hetil. 2003 Oct 5;144(40):1965-75.
3
Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.炎症性肠病的肝胆表现:肠道、药物与肝脏。
World J Gastroenterol. 2013 Nov 14;19(42):7327-40. doi: 10.3748/wjg.v19.i42.7327.
4
Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.克罗恩病和溃疡性结肠炎的肠外表现:来自一项基于人群的欧洲前瞻性起始队列研究的结果
Scand J Gastroenterol. 2015 Mar;50(3):300-5. doi: 10.3109/00365521.2014.991752. Epub 2014 Dec 23.
5
Extraintestinal manifestations in inflammatory bowel disease.炎症性肠病的肠外表现
World J Gastroenterol. 2005 Dec 14;11(46):7227-36. doi: 10.3748/wjg.v11.i46.7227.
6
Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease.抗 TNF-α 治疗在炎症性肠病肠外表现中的应用。
Eur Rev Med Pharmacol Sci. 2012 Jul;16(7):890-901.
7
Extraintestinal manifestations and complications in inflammatory bowel diseases.炎症性肠病的肠外表现及并发症
World J Gastroenterol. 2006 Aug 14;12(30):4819-31. doi: 10.3748/wjg.v12.i30.4819.
8
Hepatobiliary disorders and complications of inflammatory bowel disease.肝胆疾病与炎症性肠病的并发症。
J Dig Dis. 2011 Aug;12(4):245-56. doi: 10.1111/j.1751-2980.2011.00511.x.
9
Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.系统评价:炎症性肠病患者肝胆系统表现的流行病学。
Aliment Pharmacol Ther. 2014 Jul;40(1):3-15. doi: 10.1111/apt.12794. Epub 2014 May 11.
10
[Extraintestinal manifestations of inflammatory bowel diseases and their management].[炎症性肠病的肠外表现及其管理]
Orv Hetil. 2011 Apr 24;152(17):663-71. doi: 10.1556/OH.2011.29075.

引用本文的文献

1
Gut Hormones and Inflammatory Bowel Disease.肠道激素与炎症性肠病
Biomolecules. 2025 Jul 14;15(7):1013. doi: 10.3390/biom15071013.
2
Effectiveness of combination the photobiomodulation therapy and triamcinolone acetonide on managing oral major aphthous ulcer in Crohn's disease: A case report.光生物调节疗法与曲安奈德联合治疗克罗恩病口腔重型阿弗他溃疡的疗效:病例报告
Medicine (Baltimore). 2025 Jul 18;104(29):e43336. doi: 10.1097/MD.0000000000043336.
3
Extra intestinal manifestations may increase the risk of synchronous and metachronous development of other extraintestinal manifestations in patients with Crohn's disease.

本文引用的文献

1
Cutaneous manifestations of gastrointestinal disease: part II.皮肤表现的胃肠道疾病:第二部分。
J Am Acad Dermatol. 2013 Feb;68(2):211.e1-33; quiz 244-6. doi: 10.1016/j.jaad.2012.10.036.
2
Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease.炎症性肠病肠外表现的诊断和治疗管理。
Drugs. 2012 Dec 24;72(18):2333-49. doi: 10.2165/11638120-000000000-00000.
3
Treatment of extraintestinal manifestations in inflammatory bowel disease.炎症性肠病的肠外表现治疗。
肠外表现可能会增加克罗恩病患者发生其他肠外表现同步和异时发展的风险。
Sci Rep. 2025 Jul 1;15(1):20629. doi: 10.1038/s41598-025-07180-6.
4
Wuda Granule Alleviates DSS-Induced Colitis in Mice by Inhibiting Inflammation, Protecting Intestinal Barrier and Reducing Oxidative Stress Through Nrf2/Keap1/HO-1 Pathway.五达颗粒通过Nrf2/Keap1/HO-1通路抑制炎症、保护肠道屏障和减轻氧化应激,从而缓解小鼠DSS诱导的结肠炎。
J Inflamm Res. 2025 Jun 7;18:7301-7321. doi: 10.2147/JIR.S519483. eCollection 2025.
5
Evaluating the Impact of Co-Existent Inflammatory Bowel Disease on Hospital-Based Outcomes Among Patients With Acute Pancreatitis: An Analysis of the 2020 National Inpatient Sample Database.评估并存炎症性肠病对急性胰腺炎患者基于医院的结局的影响:对2020年全国住院患者样本数据库的分析。
Gastroenterology Res. 2025 Jun;18(3):101-107. doi: 10.14740/gr2024. Epub 2025 Jun 4.
6
Colitis can reduce the cingulate cortex neuronal density in rats.结肠炎可降低大鼠扣带回皮质的神经元密度。
BMC Gastroenterol. 2025 Mar 13;25(1):171. doi: 10.1186/s12876-025-03745-x.
7
An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice.一种丰富的生姜化合物呋喃二烯酮通过小鼠体内的外源性核受体PXR减轻肠道炎症。
Nat Commun. 2025 Feb 3;16(1):1280. doi: 10.1038/s41467-025-56624-0.
8
A Study of Dizziness or Vertigo Cases Associated with Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) in a Vertigo Outpatient Clinic.眩晕门诊中与炎症性肠病(克罗恩病和溃疡性结肠炎)相关的头晕或眩晕病例研究
J Clin Med. 2025 Jan 8;14(2):341. doi: 10.3390/jcm14020341.
9
Primary Biliary Cholangitis Associated with Ulcerative Colitis: Case Series and Literature Review.原发性胆汁性胆管炎合并溃疡性结肠炎:病例系列及文献综述
Medicina (Kaunas). 2024 Dec 30;61(1):44. doi: 10.3390/medicina61010044.
10
Hepatobiliary manifestations of inflammatory bowel disease in Saudi Arabia: A retrospective analysis.沙特阿拉伯炎症性肠病的肝胆表现:一项回顾性分析。
Saudi Med J. 2025 Jan;46(1):52-58. doi: 10.15537/smj.2025.46.1.20240758.
Digestion. 2012;86 Suppl 1:28-35. doi: 10.1159/000341950. Epub 2012 Oct 5.
4
High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort.炎症性肠病患者缺铁性贫血的高患病率但治疗不足:一项基于人群的队列研究结果。
Gastroenterol Res Pract. 2012;2012:595970. doi: 10.1155/2012/595970. Epub 2012 Jul 30.
5
AA amyloidosis: basic knowledge, unmet needs and future treatments.AA 淀粉样变性:基础知识、未满足的需求和未来的治疗方法。
Swiss Med Wkly. 2012 May 31;142:w13580. doi: 10.4414/smw.2012.13580. eCollection 2012.
6
Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics.炎症性肠病患者的神经系统并发症:生物制剂时代日益增加的相关性。
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):864-72. doi: 10.1002/ibd.23011.
7
The transition of acute to chronic bowel inflammation in spondyloarthritis.脊柱关节炎中急性到慢性肠道炎症的转变。
Nat Rev Rheumatol. 2012 Apr 17;8(5):288-95. doi: 10.1038/nrrheum.2012.42.
8
Micronutrient deficiencies in inflammatory bowel disease: from A to zinc.炎症性肠病中的微量营养素缺乏:从 A 到锌。
Inflamm Bowel Dis. 2012 Oct;18(10):1961-81. doi: 10.1002/ibd.22906. Epub 2012 Apr 5.
9
Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review.感染和炎症性疾病作为静脉血栓形成的危险因素。系统评价。
Thromb Haemost. 2012 May;107(5):827-37. doi: 10.1160/TH11-09-0611. Epub 2012 Mar 22.
10
What is the optimal treatment for anemia in inflammatory bowel disease?炎症性肠病相关贫血的最佳治疗方法是什么?
Curr Drug Deliv. 2012 Jul;9(4):356-66. doi: 10.2174/156720112801323026.